IDEAYA Biosciences (IDYA) executive compensation, 2026 proxy

Yujiro S. Hata, President and Chief Executive Officer, was paid $9.5M in 2025, down 44% from $16.9M the year before. The CEO-to-median-employee pay ratio was 28:1, on median employee pay of $335,731.

Filed
April 29, 2026
Annual meeting
June 16, 2026
Pay year
2025
Named executives
6
CEO total pay
$9.5M-44% vs prior year
CEO to median employee
28:1median $335,731
Prior say-on-pay support
78%of votes cast
CEO Base Salary
$700,0002025 fiscal year salary
CEO Option Awards
$8,418,840Grant date fair value
Say-on-Pay Support
78%Prior year favorable vote

How Hata was paid

$9.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Option awards89%Non-equity incentive4%All other compensation0%

Named executive officers

ExecutiveTotal
Yujiro S. HataPresident and Chief Executive Officer$9,512,640
Joshua Bleharski, Ph.D.Chief Financial Officer$4,147,322
Andres Ruiz BrisenoChief Accounting Officer$1,653,155
Darrin M. Beaupre, M.D., Ph.D.Chief Medical Officer$3,334,109
Michael A. White, Ph.D.Chief Scientific Officer$3,324,109
Douglas B. SnyderChief Legal Officer$1,131,560

What changed and why

  • $16.9MCEO total compensation decreased from $16,930,872 in 2024 to $9,512,640 in 2025.
  • $8.4MStock option awards for the CEO totaled $8,418,840 in 2025.
  • $378KThe annual performance-based cash bonus for the CEO was $378,000 for 2025.
  • 78%Say-on-pay received approximately 78% support from shareholders at the previous annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.